Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives.
about
Novel hormone-regulated genes in visceral adipose tissue: cloning and identification of proinflammatory cytokine-like mouse and human MEDA-7: implications for obesity, insulin resistance and the metabolic syndromeIdentifying risk factors for metabolic syndrome in biomedical text.Extremes of endogenous testosterone are associated with increased risk of incident coronary events in older women.Prospective association of serum androgens and sex hormone-binding globulin with subclinical cardiovascular disease in young adult women: the "Coronary Artery Risk Development in Young Adults" women's study.Serum magnesium concentrations in polycystic ovary syndrome and its association with insulin resistance.Are women with polycystic ovarian syndrome at a high risk of non-alcoholic Fatty liver disease; a meta-analysisA nationwide population-based retrospective cohort study of the risk of uterine, ovarian and breast cancer in women with polycystic ovary syndrome.Differences in the skin-surface laser Doppler signals between polycystic ovary syndrome and normal subjects.Prenatal testosterone exposure induces hypertension in adult females via androgen receptor-dependent protein kinase Cδ-mediated mechanism.Effects of Probiotic Supplementation on Pancreatic β-cell Function and C-reactive Protein in Women with Polycystic Ovary Syndrome: A Randomized Double-blind Placebo-controlled Clinical Trial.Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis.Heart Rate Changes in Electroacupuncture Treated Polycystic Ovary in RatsGlucose, insulin, diabetes and mechanisms of arterial dysfunction.The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trialsPrevalence of hepatic steatosis in women with polycystic ovary syndrome.Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome.The effects of insulin sensitizers on the cardiovascular risk factors in women with polycystic ovary syndrome.Acute post-bariatric surgery increase in orexin levels associates with preferential lipid profile improvement.Metabolic and carbohydrate characteristics of different phenotypes of polycystic ovary syndrome.Management of polycystic ovary syndrome.Tissue plasminogen activator and plasminogen activator inhibitor 1 in obese and lean patients with polycystic ovary syndrome.Distinction of hypertriglyceridemic waist phenotype from simple abdominal obesity: interaction with sex hormone-binding globulin levels to confer high coronary risk.Perinatal testosterone exposure potentiates vascular dysfunction by ERβ suppression in endothelial progenitor cells.Assessment of cardiovascular autonomic function in patients with polycystic ovary syndrome.Association of sympathovagal imbalance with cardiovascular risks in patients with polycystic ovary syndrome.Cardiovascular risk factors in polycystic ovary syndrome.The relationship of the Fas 670 A/G gene polymorphism with cardiovascular risk factors in polycystic ovary syndrome (PCOS) patients.Salusins, newly identified regulators of hemodynamics and mitogenesis, increase in polycystic ovarian syndrome.Is the risk for cardiovascular disease increased in all phenotypes of the polycystic ovary syndrome?Influence of obesity on atherogenic dyslipidemia in women with polycystic ovary syndrome.Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome.Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study.Risk factors associated with metabolic syndrome and cardiovascular disease among women with polycystic ovary syndrome in Tabuk, Saudi Arabia.Serum orexin-A (OXA) level decreases in polycystic ovarian syndrome.Expression levels of vascular cell adhesion molecule-1 in young and nonobese women with polycystic ovary syndrome.Vascular compliance in women with polycystic ovary syndrome and healthy women.Hypertension caused by prenatal testosterone excess in female sheep.Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS).A Review on the Nonlinear Dynamical System Analysis of Electrocardiogram Signal.Activation of eNOS by D-pinitol Induces an Endothelium-Dependent Vasodilatation in Mouse Mesenteric Artery.
P2860
Q24306922-3CCC15D6-A166-4906-88BE-422B48A77077Q33359171-6F6E57FB-C789-4BDE-87E9-3F8FCE52AC80Q33736113-A8A63200-18A3-45AE-B981-D3A856BA8FCBQ34113211-08574D72-ADFE-4E4A-BF77-63A5B6A07374Q34194665-7E6E083F-97E0-4D11-8174-AE2A830B33F3Q34864638-DF967E76-D1C1-4B89-8CFD-2995E868919CQ34960097-36BACDE5-D1BD-4B05-8BF8-2426F96F82D9Q35015612-30EDBD93-068C-4002-B3F2-70F122133864Q35079544-93B06E92-6982-468F-8810-FB4AF1DA0FB8Q35293427-C868EBF7-7A9F-4349-9141-319AC94D96B1Q36058191-DC846844-D530-46F7-AEA8-E042E2C99892Q36830988-24DE121A-2B10-4FB8-9FD0-DE4D33CD6277Q36854157-5DF85EA0-AEA6-4445-AE4F-7786727DCBDDQ36971967-11798488-827E-4406-A130-2070A55A8E2FQ37019757-FF85226C-C3AC-4250-96E1-1DBD599C4AE2Q37061257-1057678E-4272-46A0-A897-E41D4B56E916Q37402281-185D3218-C129-4C17-B4BB-289EEF0DBD89Q37439308-FAD071A4-21B7-4A6E-A5B0-470736C139BDQ37489471-A1D75E3C-2DF1-4C0F-827A-D8C948C69721Q37608413-13A83AD2-F1F0-448E-B266-339C4F9AF9E7Q39869942-BCF0276F-EED6-43CA-B28F-1216E7261121Q40474673-01783E6B-67FE-40C5-A08D-B37E1E3F6FF1Q41410726-D00CA2B3-4780-4D01-8359-D1A262ADC8C2Q42446085-41DABE0E-D6BA-40E5-B0F7-58439889656BQ42459575-D27DB019-5CC8-490C-BDBF-A8C88B363300Q42471238-5C288926-4B88-496E-A078-6B055E752F0BQ43283452-0D0FC8C9-7845-471F-A302-5EB458576C54Q44205159-FB228B1D-52F6-49D2-8075-D24772C530AAQ44774170-8D05188C-7441-4686-A030-6E08E5F3C087Q45146598-20CA9702-BD7A-46D4-81D6-6138F1F3C166Q46104097-84F5679F-0AB2-4CCE-A96B-7F6739F4B763Q47206352-DDDEAA3C-EA46-4012-8AD1-1742A0544154Q49166269-AB1F3A92-FA5E-43BD-AADA-D2768E755FE5Q51345694-11BB21E4-A6D0-4BE8-A810-EA272A8B33EFQ51359264-7949A6FE-834E-4CC4-8F3B-DE8291EA073CQ51466246-BDBA9756-66D3-4F28-878C-64655749CFC0Q51764429-7241DD02-A410-420D-90DA-CCF6F8D66DADQ52841821-A8C00D8F-0FE8-4389-8102-CB9E412E2426Q55032290-C3A1906B-6CC3-4D6C-8C5C-1493EF1957D7Q55380633-46A56F05-1D56-4517-A54A-CD3C56105534
P2860
Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives.
@ast
Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives.
@en
type
label
Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives.
@ast
Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives.
@en
prefLabel
Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives.
@ast
Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives.
@en
P1433
P1476
Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives
@en
P2093
Andrea J Cussons
Bronwyn G A Stuckey
P304
P356
10.1016/J.ATHEROSCLEROSIS.2005.10.007
P50
P577
2005-11-28T00:00:00Z